Curasan AG | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,992.00
1,830.00
1,333.00
2,085.00
3,998.00
Depreciation, Depletion & Amortization
368.00
361.00
347.00
332.00
434.00
Other Funds
1,446.00
186.00
224.00
262.00
7.00
Funds from Operations
80.00
1,335.00
1,907.00
2,182.00
3,371.00
Changes in Working Capital
1,772.00
752.00
4.00
56.00
724.00
Net Operating Cash Flow
1,852.00
583.00
1,903.00
2,238.00
2,647.00
Capital Expenditures
346.00
115.00
2,785.00
498.00
1,114.00
Net Investing Cash Flow
346.00
115.00
2,785.00
498.00
1,114.00
Issuance/Reduction of Debt, Net
35.00
37.00
36.00
8.00
2.00
Net Financing Cash Flow
35.00
1,475.00
918.00
2,154.00
4,802.00
Net Change in Cash
2,233.00
777.00
36.00
582.00
1,041.00
Free Cash Flow
2,158.00
698.00
1,751.00
2,361.00
3,161.00
Deferred Taxes & Investment Tax Credit
98.00
52.00
3.00
691.00
200.00
Change in Capital Stock
-
1,512.00
954.00
2,162.00
4,804.00

About Curasan

View Profile
Address
Lindigstraße 4
Aschaffenburg Bayern (Bavaria) 63801
Germany
Employees -
Website http://www.curasan.de
Updated 09/14/2018
curasan AG engages in the developing, manufacturing and marketing of regenerative medicine. Its products cover the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company was founded by Hans Dieter Rössler in 1988 and is headquartered in Aschaffenburg, Germany.